1. Y. Mishima and T. Shimakage, Thermal neutron capture treatment of malignant melanoma using 10B-dopa and nB12-chlorpromazine compounds, in: “Pigment Cell,” 2:394, V. Riley, ed., S. Karger, Basel (1976).
2. M. Ichihashi, H. Fukuda, J.K. Brown, M.H. Mountford, B.J. Allen, J.G. Wilson, and Y. Mishima, In vitro evaluation of for mealanoma at Moata - joint work between Japan and Australia BNCT reasearch teams in: “Progress in Neutron Capture Therapy for Cancer,” B.J. Allen et al. ed., Plenum Press, New York (1992).
3. Y. Mishima, M. Ichihashi, T. Nakanishi, M. Tsuji, M. Ueda, T. Nakagawa, and T. Suzuki, Cure of malignant melanoma by single thermal neutron capture treatment using melanoma seeking compounds: 10B/melanogenesis interaction to in vitro / in vivo radiobiological analysis to preclinical studies, in: “Proc. 1st International Symposium on NCT,” R.G. Fairchild and G.L. Brownell, eds., U.S. Government Printing Office (1984).
4. Y. Mishima, C. Honda, M. Ichihashi, H. Obara, J. Hiratsuka, H. Fukuda, H. Karashima, T. Kobayashi, K. Kanda andY. Yoshino, Treatment of malignant melanoma by single neutron capture treatmentwith melanoma-seeking 10B-Compound, Lancet 11:388–389 (1989).
5. H. Fukuda, K. Ando, C. Honda, M. Ichihashi, Y. Mishima, J. Hiratsuka, T. Kobayashi, and K. Kanda, Tolerance limits of normal skin treated by a single thermal neutron capture therapy, in: “Progress in Neutron Capture Therapy for Cancer,” B.J. Allen et al. ed., Plenum Press, New York (1992).